https://bond.bio/contact daily 0.75 2025-04-02 https://bond.bio/science-pipeline daily 0.75 2023-11-28 https://images.squarespace-cdn.com/content/v1/60045b52399ee75bb3ff31e2/1612535856257-M4W0XWOQKOWMSWDSJF2H/multigenerational-family-gathering.jpg Science and Pipeline - HH is a hereditary disease caused by a gene mutation passed from parents to children. There are an estimated 150,000 patients in the US and over 1,000,000 patients in Europe with iron overload resulting from HH. https://bond.bio/home daily 1.0 2022-04-05 https://bond.bio/leadership daily 0.75 2023-11-28 https://images.squarespace-cdn.com/content/v1/60045b52399ee75bb3ff31e2/1611453941651-WVPCY8AQ5YA84OS3GVHP/Mike+Riley+is+Chief+Operating+Officer+of+Bond+Biosciences Leadership https://images.squarespace-cdn.com/content/v1/60045b52399ee75bb3ff31e2/1611453890323-BXA0DRSWS19KJMB6RAW0/Corey+Berkland%2C+PhD%2C+CEO+of+Bond+Biosciences Leadership Cory Berkland, PhD, is President, CEO and Chairman of the Board of Bond Biosciences. https://bond.bio/leadership-tim-opler-director daily 0.75 2021-02-15 https://bond.bio/leadership-mike-riley-coo daily 0.75 2021-02-15 https://images.squarespace-cdn.com/content/v1/60045b52399ee75bb3ff31e2/1611453941651-WVPCY8AQ5YA84OS3GVHP/Mike+Riley+is+Chief+Operating+Officer+of+Bond+Biosciences Mike Riley, MSc, JD, COO and Co-Founder MikeRiley, MSc, JD, COO, Co-Founder Bond Biosciences https://bond.bio/leadership-peter-schultz-scientific-advisor daily 0.75 2021-03-03 https://bond.bio/leadership-cory-berkland-ceo daily 0.75 2021-03-03 https://images.squarespace-cdn.com/content/v1/60045b52399ee75bb3ff31e2/1611453890323-BXA0DRSWS19KJMB6RAW0/Corey+Berkland%2C+PhD%2C+CEO+of+Bond+Biosciences Cory Berkland, PhD, CEO and Co-Founder Cory Berkland, PhD, CEO, Co-Founder Bond Biosciences https://bond.bio/leadership-curtis-scribner-scientific-advisor daily 0.75 2021-02-15 https://bond.bio/leadership-mike-beckloff-director daily 0.75 2021-02-15 https://bond.bio/terms-of-use daily 0.75 2025-03-29